Research and Markets: 2012 CRO Quality Benchmarking - Phase I Service Providers
* Reuters is not responsible for the content in this press release.
http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130207:nBw075798a DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/pqp7x5/2012_cro_quality) has announced the addition of the "2012 CRO Quality Benchmarking - Phase I Service Providers" report to their offering. This report, like our other CRO Benchmarking reports, is intended to provide the pharmaceutical and biotech industry and their service providers with third-party, objective data to better evaluate, select, and improve clinical outsourcing. This report focuses on providers of Phase I clinical pharmacology services. Publication Overview WHAT YOU'LL LEARN For Sponsors: Make more informed CRO selection decisions by understanding which Phase I CROs are the best fit for your individual organization's needs For Phase I Units: - Improve clinical pharmacology service quality and create loyal customers - Develop more effective RFP responses and increase new business wins - Better position your Phase I unit to the competition - Develop marketing messages that will resonate with your buyers ATTRIBUTES EVALUATED Each respondent was asked to rank the companies they have used in the past 18 months, across the following service quality attributes: - Quality of the Phase I unit's lead investigator - Quality of clinic staff - Technical expertise - Ability to quickly recruit volunteers or patients - Meeting schedules and timelines - Breadth of services - Range of tests, specialized equipment - Low cost - Overall value MAJOR SECTIONS Phase I Outsourcing Behaviors, Attitudes, Beliefs, and Intentions Phase I Service Provider Selection Drivers Phase I Service Provider Performance Study Data Companies Mentioned Companies Included: - Chiltern - INC Research - Mepace - Premier Research - Rho - SGS Life Sciences - Siro Clinpharm - US Oncology Companies with Full Profiles: - Bioclinica - Cetero - Charles River - Covance - DCRI - Duke - ICON - PAREXEL - PharmaNet/i3 - PPD - PRA - Quintiles For more information visit http://www.researchandmarkets.com/research/pqp7x5/2012_cro_quality Research and Markets Laura Wood, Senior Manager. firstname.lastname@example.org U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biotechnology, Pharmaceuticals Copyright Business Wire 2013